Latest Share Issuance News

AssetOwl Limited proposes converting $163,411 of debt into 100 million new shares, continuing its strategic debt reduction efforts ahead of shareholder approval.

Cauldron Energy has terminated its purchase agreement for river sand leases at Carnarvon and Derby, retaining the Onslow tenements with no further payments required, including cancellation of 2 million shares.

Robotics innovator FBR Limited has closed its Share Purchase Plan, securing approximately $700,000 in applications and preparing to issue new shares by early September.

MA Financial Group has completed its acquisition of IP Generation, issuing over 11 million shares upfront and setting a $10.4 million deferred payment split between cash and shares.

Lode Resources has agreed to sell its Webbs Consol Silver Project to Rapid Critical Metals for A$3.75 million in cash, a significant shareholding, and a royalty, positioning both companies for strategic growth in New South Wales.

Astron Limited has finalized its move from Hong Kong to Australia, issuing new securities on a two-for-one basis and preparing for ASX trading starting September 1, 2025.

The Takeovers Panel has declined to intervene in PointsBet’s issuance of over 10 million new shares during a fierce takeover contest, affirming the board’s discretion amid competing bids from betr and MIXI Australia.

AssetOwl Limited reports a modest net profit for FY2025, driven by a significant gain on debt extinguishment, while grappling with ASX suspension and ongoing going concern challenges.

OMG Group Limited reported a 63% revenue surge to $4.13 million in FY2025, driven by its acquisition of Good Oats Pty Ltd and strong growth in its Blue Dinosaur brand. The company also trimmed its loss by 18% and improved gross margins, signaling operational progress despite ongoing challenges.

Victor Group Holdings has sharply reduced its FY25 loss to $275,449 from $3.53 million the prior year, while expanding its fintech presence through strategic stakes in LIT Technology and iRich Finance.

Prescient Therapeutics has completed a $3 million share placement, bolstering its clinical development programs for innovative cancer treatments including PTX-100 and novel cell therapies.

Energy Action Limited reported a robust FY25 with a 12% revenue increase and a 247% jump in statutory profit, underpinned by disciplined expense management and contract growth.